price month
 close
guid cat meow
exceed estim better revenu off-set slightli weaker
profit factor line ad focu initi
ep guidanc nice ahead consensu
estim midpoint help instil greater enthusiasm
share rais ep reflect better
profit well higher interest expens off-set lower tax
rate pt move higher view
handili beat estimate us plan notabl
strength companion anim vs estimate driven new product
apoquel cytopoint simparica abaxi us livestock vs
also exceed plan strength premium cattl product poultri
swine ex fx slightli estimate
strength companion apoquel simparica abaxi off-set
modest improv livestock albeit note strength
aquacultur swine poultri new product demand emerg
market gross margin declin bp bp plan
anticip season calendar shift admin expens rose bp
bp plan contribut ebit margin deterior bp
bp estim await cash flow balanc sheet data
pre-cal view share run reiter anim health top pick
share rise latest revenu ep upsid investor
focu initi ep guidanc ahead consensu
reflect healthi organ top-line growth ex fx abax
encompass estimate evid continu contribut
new product
importantli guidanc impli continu oper margin expans
bp despit abaxi dilut key compon outperform view
enhanc clariti help instil greater convict earn
growth prospect top-line strength dilig cost manag risk
includ shift fundament demand slower traction newer product
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
global leader develop anim health
therapeut livestock companion anim diversifi
portfolio product line directli market countri
industri largest sale forc
price feb rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
blue sky scenario assum meaning profit
contribut oper effici initi greater
expect adopt futur recent launch product
substanti share gain well stronger anticip growth
anim health fundament
grey sky scenario assum lower expect
ramp profit weaker traction new product potenti
distribut manufactur disrupt fx macroeconom
headwind weak companion product anim
compani mention price
